Last reviewed · How we verify
NCT03900351
Influence of Virtual Reality Games on Knee Proprioception After Anterior Cruciate Ligament Reconstruction (ACLR)
NA trial testing Wii fit protocol of virtual reality games in Motor Activity in 30 participants. Completed in 13 June 2019.
6 June 2019
Quick facts
| Lead sponsor | University of Jazan |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 30 |
| Start date | 7 April 2019 |
| Primary completion | 6 June 2019 |
| Estimated completion | 13 June 2019 |
| Sites | 1 location across Saudi Arabia |
Drugs / interventions tested
- Wii fit protocol of virtual reality games
- Regular exercise rehabilitation protocol
Conditions studied
- Motor Activity — all drugs for Motor Activity →
- Proprioceptive Disorders — all drugs for Proprioceptive Disorders →
- Balance; Distorted — all drugs for Balance; Distorted →
Sponsor
University of Jazan
Who can join
Adults 20 to 30, male only, with Motor Activity or Proprioceptive Disorders. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Influence of virtual reality games(Wii Fit) on knee proprioception after anterior cruciate ligament reconstruction (ACLR) will be measured in 30 postoperative patients. The age of participants will be ranged from 20 to 30 years old. Subjects will be randomly assigned to Group A is the study group and Group B is the control group.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03900351
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Motor Activity
Currently open trials in the same condition.
- NCT07453537 — Cranberry Polyphenols and Stress Resilience During Multitasking in Healthy Adults · NA · recruiting
- NCT07373626 — Physical Activity Trends in Cancer Survivors Treated at the 'MOvement and REhabilitation' Clinic · recruiting
- NCT06999616 — Physical Activity in Cancer Patients in an Oncology Day Clinic - Implementing a Person-centered Program Led by Nurses · recruiting
- NCT07447882 — Unilateral M1 Anodal tDCS to Enhance Learning in a Gross Movement Videogame Task · NA · active not recruiting
- NCT07202702 — Modulation of Motor Learning Via tDCS in a Dexterous Video Game Task · NA · recruiting
Other University of Jazan trials
Trials by the same sponsor.
- NCT07324928 — Effect of Ferric Sulphate and Putty MTA as Pulpotomy Agent in Vital Primary Teeth · NA · enrolling by invitation
- NCT07324915 — EFFECT OF BUZZY BEE TO REDUCE PAIN PERECEPTION DURING INFERIOR ALVEOLAR NERVE BLOCK IN CHILDREN - A CROSS OVER STUDY · NA · enrolling by invitation
- NCT07166068 — The Effect of Mobilization on Inflammatory Biomarkers in Patients With Knee Osteoarthritis. · NA · recruiting
- NCT06698380 — The Effect of Mirror Therapy on Upper Extremity Motor Function in Stroke Rehabilitation · NA · recruiting
- NCT06692569 — The Effect of Modified Constraint Induced Movement Therapy on Upper Extremity Function in Stroke Rehabilitation · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03900351 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Jazan
- Last refreshed: 14 June 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03900351.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing